Change in IGF-1 was correlated with improvements in NAS (r = -.547; P = .019) and NASH score (Fig. 6C) and the reduction of hepatic steatosis measured by MRI (Fig. 6D). This evidence concerns the gene IGF1 and metabolic dysfunction-associated steatohepatitis.